MedPath

Smoking Cessation Program in the Preadmission Clinic

Not Applicable
Completed
Conditions
Smoking
Interventions
Drug: Smoking cessation counselling group
Registration Number
NCT01320462
Lead Sponsor
University Health Network, Toronto
Brief Summary

Main Hypothesis: The multifaceted intervention (preoperative counseling, pharmacotherapy by varenicline and follow up by quit line) in the preoperative clinic is more effective than the simple preoperative smoking intervention (brief advice and provision of information about the quit lines ) in terms of short-term and long-term quit rates

Objectives: To evaluate the effectiveness and feasibility of a multifaceted intervention (preoperative counseling, pharmacotherapy by varenicline and follow up by the quit line) in the preoperative clinic to help surgical patients quit smoking perioperatively and for the long-term.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
296
Inclusion Criteria
  • Patients who smoke more than 10 cigarettes per day for more than 1 year
  • And had no period of smoking abstinence longer than 3 months in the past year.
  • Patients who are scheduled to have any elective surgery next 7 to 60 days. Patients > 18 years of age
Exclusion Criteria
  • Patients unwilling or unable to give informed consent
  • Patients who are pregnant and breast feeding
  • Patients with any psychiatric disorder
  • Patients who used nicotine replacement / bupropion within previous 3 months
  • Cardiovascular disease within the past 6 months
  • Any serious or unstable disease within the past 6 months
  • Drug or alcohol abuse within the past year.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Smoking cessation groupSmoking cessation counselling groupCounselling, Pharmacotherapy and Smokers Help Line
Primary Outcome Measures
NameTimeMethod
pre-surgery counseling for quit smoking1 year after surgery

In order to determine the prevalence of abstinence in long-term follow up (4, 12, 24 and 52 weeks), patients will be asked the following questions:

* Have you been abstinent from smoking for the past four weeks? (4-week abstinence)

* Do you currently smoke cigarettes everyday? (point prevalence)

* Have you been abstinent from smoking since the last time you quit smoking? (continuous abstinence)

Secondary Outcome Measures
NameTimeMethod
perioperative complications3 months after surgery

Secondary outcome measures that will be studied are as follows: The changes in the number of cigarettes consumed per day or 'stage of change' at 4, 12, 24 and 52 weeks after the initial assigned target quit date. The incidence of perioperative complications (until 30 days after surgery) as well as medication-related adverse events (and serious adverse events) will also be recorded (only those who in the smoking-cessation program).

Trial Locations

Locations (2)

Mount Sinai Hospital, Department of Anesthesia

🇨🇦

Toronto, Ontario, Canada

Toronto Western Hospital, Department of Aneshtesia

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath